Report
Positron emission tomography (PET) in malignant lymphoma
Report documents
-
Executive summary of the final report
Positron emission tomography (PET) in malignant lymphoma
-
Final report
Positron emission tomography (PET) in malignant lymphoma
-
Documentation and appraisal of comments on the preliminary report
Positron emission tomography (PET) in malignant lymphoma
-
Preliminary report
Positron emission tomography (PET) in malignant lymphoma
-
Report plan version 1.0
Positron emission tomography (PET) in malignant lymphoma
-
Documentation and appraisal of comments on the report plan (preliminary version)
Positron emission tomography (PET) in malignant lymphoma
-
Report plan - preliminary version
Positron emission tomography (PET) in malignant lymphoma
Press releases
Benefit of PET in patients with malignant lymphoma remains unclear
No trials available on detecting tumour recurrence – Implication for determining tumour stage not known
Additional information
IQWiG health information
Positron emission tomography (PET) scans are used to see metabolic activity in the tissue of the body. To do this, multiple images are created to show that part of the body layer by layer.
Federal Joint Committee (G-BA)
2016-01-21 G-BA decision was published.
Project details
- Project no.
- D06-01A
- Commission
- Commission awarded on 02.04.2007 by the Federal Joint Committee (GBA).
- Report type
- Report
- Status
- Commission completed
- Department/Division
- Non-Drug Interventions
- Topic
- Cancer, Diagnostics